Song Y - Search Results

1

Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

Huo G, Song Y, Chen P. Huo G, et al. Among authors: song y. J Gynecol Oncol. 2024 Nov;35(6):e86. doi: 10.3802/jgo.2024.35.e86. Epub 2024 Apr 8. J Gynecol Oncol. 2024. PMID: 38606826 Free PMC article.

2

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis.

Zhang Q, Huo GW, Zhang HZ, Song Y. Zhang Q, et al. Among authors: song y. Open Med (Wars). 2020 Jun 10;15(1):447-456. doi: 10.1515/med-2020-0110. eCollection 2020. Open Med (Wars). 2020. PMID: 33313405 Free PMC article.

3

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis.

Huo GW, Zuo R, Song Y, Chen WD, Chen WM, Chong DQ, Zhang HM, Jia SS, Chen P. Huo GW, et al. Among authors: song y. Open Med (Wars). 2021 May 11;16(1):728-736. doi: 10.1515/med-2021-0272. eCollection 2021. Open Med (Wars). 2021. PMID: 34013044 Free PMC article.

4

A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors.

Huo G, Wang Y, Chen J, Song Y, Zhang C, Guo H, Zuo R, Zhu F, Cui J, Chen W, Chen W, Chen P. Huo G, et al. Among authors: song y. Front Oncol. 2021 May 25;11:692136. doi: 10.3389/fonc.2021.692136. eCollection 2021. Front Oncol. 2021. PMID: 34113576 Free PMC article.

5

The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis.

Huo GW, Zhu FY, Zuo R, Song Y, Chen WD, Chen WM, Zhang HM, Jia SS, Chen P. Huo GW, et al. Among authors: song y. Transl Cancer Res. 2021 Jul;10(7):3389-3403. doi: 10.21037/tcr-21-125. Transl Cancer Res. 2021. PMID: 35116644 Free PMC article.

6

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States.

Huo G, Song Y, Liu W, Cao X, Chen P. Huo G, et al. Among authors: song y. Front Pharmacol. 2024 Mar 28;15:1300183. doi: 10.3389/fphar.2024.1300183. eCollection 2024. Front Pharmacol. 2024. PMID: 38606181 Free PMC article.

7

Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer.

Huo G, Song Y, Chen P. Huo G, et al. Among authors: song y. J Gynecol Oncol. 2024 Sep;35(5):e83. doi: 10.3802/jgo.2024.35.e83. Epub 2024 Apr 3. J Gynecol Oncol. 2024. PMID: 38606824 Free PMC article.

8

Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis.

Huo G, Song Y, Chen X, Chen P. Huo G, et al. Among authors: song y. Transl Lung Cancer Res. 2024 Apr 29;13(4):839-848. doi: 10.21037/tlcr-24-8. Epub 2024 Apr 25. Transl Lung Cancer Res. 2024. PMID: 38736499 Free PMC article.

9

Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer.

Huo G, Song Y, Liu W, Guo H, Chen P. Huo G, et al. Among authors: song y. Front Pharmacol. 2024 Jun 20;15:1391896. doi: 10.3389/fphar.2024.1391896. eCollection 2024. Front Pharmacol. 2024. PMID: 38966552 Free PMC article.

10

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis.

Wang J, Zhang K, Liu T, Song Y, Hua P, Chen S, Li J, Liu Y, Zhao Y. Wang J, et al. Among authors: song y. Front Oncol. 2022 Sep 5;12:974684. doi: 10.3389/fonc.2022.974684. eCollection 2022. Front Oncol. 2022. PMID: 36158679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,637 results

Search Page

Filters